ArticleAmerican journal of cancer research2022

Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis.

Andrew J MasseyPubMed ↗Full text ↗

No numbers read from the abstract.